Literature DB >> 8038282

A perspective on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk model.

J J Filiano1, H C Kinney.   

Abstract

Neuropathologic studies in SIDS victims support the concept that they are not entirely 'normal' prior to death, but rather possess underlying vulnerabilities which put them at risk for sudden death. This concept forms a key link in a triple-risk model for the pathogenesis of SIDS proposed by us. According to this model, sudden death in SIDS results from the intersection of three overlapping factors: (1) a vulnerable infant; (2) a critical developmental period in homeostatic control, and (3) an exogenous stressor(s). An infant will die of SIDS only if he/she possesses all three factors; the infant's vulnerability lies latent until he/she enters the critical period and is subject to an exogenous stressor. According to this model, heterogeneous disorders may make the infant vulnerable to sudden death during the critical period, as potentially exemplified by two previously reported lesions in SIDS brains (arcuate nucleus hypoplasia and subtle hypomyelination). Nevertheless, the triple-risk model does not preclude the possibility that the majority of SIDS deaths will be explained by a single common pathway upon which multiple stressors impinge to produce sudden death during the critical period.

Entities:  

Mesh:

Year:  1994        PMID: 8038282     DOI: 10.1159/000244052

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  156 in total

1.  Which sleep position is best for infants?

Authors:  P Kumar; S Singhi
Journal:  Indian J Pediatr       Date:  1995 Mar-Apr       Impact factor: 1.967

2.  Application of a classification system focusing on potential asphyxia for cases of sudden unexpected infant death.

Authors:  Brad Randall; Kent Donelan; Mark Koponen; Mary Ann Sens; Henry F Krous
Journal:  Forensic Sci Med Pathol       Date:  2011-11-11       Impact factor: 2.007

3.  Comparative epidemiology of sudden infant death syndrome and sudden intrauterine unexplained death.

Authors:  J F Frøen; M Arnestad; A Vege; L M Irgens; T O Rognum; O D Saugstad; B Stray-Pedersen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

Review 4.  The molecular autopsy: should the evaluation continue after the funeral?

Authors:  David J Tester; Michael J Ackerman
Journal:  Pediatr Cardiol       Date:  2012-02-04       Impact factor: 1.655

5.  Loss-of-function mutations in the KCNJ8-encoded Kir6.1 K(ATP) channel and sudden infant death syndrome.

Authors:  David J Tester; Bi-Hua Tan; Argelia Medeiros-Domingo; Chunhua Song; Jonathan C Makielski; Michael J Ackerman
Journal:  Circ Cardiovasc Genet       Date:  2011-08-11

6.  Assessment of Safe Sleep: Validation of the Parent Newborn Sleep Safety Survey.

Authors:  Leanne Whiteside-Mansell; Rosemary Nabaweesi; Alison Rose Caballero; Samantha Hope Mullins; Beverly Kaye Miller; Mary Elizabeth Aitken
Journal:  J Pediatr Nurs       Date:  2017-03-08       Impact factor: 2.145

7.  Racial and Ethnic Trends in Sudden Unexpected Infant Deaths: United States, 1995-2013.

Authors:  Sharyn E Parks; Alexa B Erck Lambert; Carrie K Shapiro-Mendoza
Journal:  Pediatrics       Date:  2017-05-15       Impact factor: 7.124

8.  Sudden infant death syndrome in mice with an inherited mutation in RyR2.

Authors:  Nitin Mathur; Subeena Sood; Sufen Wang; Ralph J van Oort; Satyam Sarma; Na Li; Darlene G Skapura; J Henri Bayle; Miguel Valderrábano; Xander H T Wehrens
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12

Review 9.  Cardiorespiratory coupling in health and disease.

Authors:  Alfredo J Garcia; Jenna E Koschnitzky; Tatiana Dashevskiy; Jan-Marino Ramirez
Journal:  Auton Neurosci       Date:  2013-03-13       Impact factor: 3.145

10.  Pituitary adenylate cyclase-activating polypeptide: Postnatal development in multiple brain stem respiratory-related nuclei in the rat.

Authors:  Qiuli Liu; Margaret T T Wong-Riley
Journal:  Respir Physiol Neurobiol       Date:  2018-10-22       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.